CXCL13 is a chemokine which is upregulated within the CNS in multiple sclerosis, Lyme neuroborreliosis, and other inflammatory diseases and is increasingly clinically useful as a biomarker. This review provides background for understanding its function in the immune system and its relationship to ectopic lymphoid follicles. Also reviewed are its utility in multiple sclerosis and Lyme neuroborreliosis and potential problems in its measurement. CXCL13 has the potential to be an exceptionally useful biomarker in a range of inflammatory diseases.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11673926 | PMC |
| http://dx.doi.org/10.3390/biom14121541 | DOI Listing |
Publication Analysis
Top Keywords
multiple sclerosis
12
utility multiple
8
sclerosis lyme
8
lyme neuroborreliosis
8
inflammatory diseases
8
cxcl13 biomarker
4
biomarker background
4
background utility
4
sclerosis cxcl13
4
cxcl13 chemokine
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!